105 results
Page 2 of 6
8-K
EX-99.2
eu0xil
14 Apr 23
Other Events
12:38pm
8-K
EX-99.1
bpf6wgge1ec6uor60c4k
14 Apr 23
Other Events
12:38pm
8-K
EX-99.1
lj9jihomsd 3uxlkl
16 Dec 22
Ocugen Announces OCU400 Receives Orphan Drug Designations for Retinitis Pigmentosa and Leber Congenital Amaurosis
6:41am
8-K
EX-99.2
7yc1y
16 Dec 22
Ocugen Announces OCU400 Receives Orphan Drug Designations for Retinitis Pigmentosa and Leber Congenital Amaurosis
6:41am
8-K
EX-99.1
l7o48h md
8 Nov 22
Other Events
9:12am
8-K
EX-99.2
4nzz3sl1vg1z8kug
8 Nov 22
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
7:37am
8-K
EX-99.1
2339howew8 kx0ucgf
8 Nov 22
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
7:37am
8-K
EX-99.1
lglcj22v n2cv3rgf
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
EX-99.2
t7nn0
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
EX-99.1
355eho8azz5az5
14 Sep 22
Ocugen Announces Publication of a Comprehensive Review of BBV152 In Frontiers In Immunology
4:05pm
8-K
EX-99.1
7gtsh
26 Aug 22
Other Events
5:04pm
8-K
EX-99.1
hs6c 3jq6rp76
17 Aug 22
Other Events
4:03pm
8-K
EX-99.1
oj0gng8
16 Aug 22
Other Events
4:09pm
8-K
EX-99.1
afa 141a4
5 Aug 22
Ocugen Provides Business Update & Second Quarter 2022 Financial Results
7:35am
424B5
ozk28pi l2xpcyfrb
10 Jun 22
Prospectus supplement for primary offering
4:56pm
8-K
EX-99.1
2s9cm zid43hd3wdo
24 May 22
Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition
7:36am
8-K
EX-99.1
dw84 fjsl
23 May 22
Other Events
9:02am
8-K
EX-99.1
ua3ohajjg09 p9r7i5d
6 May 22
Ocugen Provides Business Update and First Quarter 2022 Financial Results
6:44am
8-K
EX-99.2
etx8zu8 152r9qdj7ql
6 May 22
Ocugen Provides Business Update and First Quarter 2022 Financial Results
6:44am
8-K
EX-99.3
6556k060zgo3
6 May 22
Ocugen Provides Business Update and First Quarter 2022 Financial Results
6:44am